MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-33-0002048
Dermazone Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹11.44 Cr
▲ 22% YoY
Net profit · FY 2024
₹33.04 Lakh
Net margin 2.9%
EBITDA · FY 2024
₹50.09 Lakh
EBITDA margin 4.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
25
Provident fund records
Directors on board
3
As per MCA filings
About Dermazone Pharmaceuticals Private Limited
Data last updated:
Dermazone Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2020PTC341612. Its GSTIN is 36AAHCD8225G1ZM (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Venkata Smita Sistla and Vara Lakshmi Bikkasani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C P Talao Road No 27 Wagale Estate, Thane, Maharashtra, India – 400604.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.44 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹33.04 Lakh (net margin 2.9%) and EBITDA of ₹50.09 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 71% over three years.
The company has about 25 employees on its provident fund (EPFO) records.
Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Dermazone Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-33-0002048). For more details, the company can be reached via its website dermazone.in.
Company details
CIN U24230MH2020PTC341612
Registration Number 341612
Incorporation Date 09 July 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification MSME
Udyam Registration UDYAM-MH-33-0002048
Key People
Venkata Smita Sistla Director Vara Lakshmi Bikkasani Director Venkata Durga Prasad Kadambala Director Recognitions & Rankings of Dermazone Pharmaceuticals
Contact details
Dermazone Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is dermazone.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC P Talao Road No 27 Wagale Estate, Thane, Maharashtra, India – 400604
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dermazone Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Dermazone Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dermazone Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dermazone Pharmaceuticals Private Limited, buy the company report.
Financials of Dermazone Pharmaceuticals Private Limited
FY 2024 filings availableDermazone Pharmaceuticals Private Limited reported revenue of ₹11.44 Cr (up 22% YoY) for FY 2024.
Revenue · FY 2024
₹11.44 Cr ▲ 22%
Net profit · FY 2024
₹33.04 Lakh margin 2.9%
EBITDA · FY 2024
₹50.09 Lakh margin 4.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 71%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 217%
Revenue has grown at a compounded annual rate (CAGR) of 71% over three years, including 22% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹50.09 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹33.04 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.4% | |||
| Net Profit Margin | 2.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dermazone Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dermazone Pharmaceuticals Private Limited
Dermazone Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Smita Sistla Also directs: Skinzone Pharmaceuticals India Private Limited | Director | 03 Oct 2020 | 6 Years 0 Months | Current |
| Vara Lakshmi Bikkasani Also directs: Skinzone Pharmaceuticals India Private Limited | Director | 09 Jul 2020 | 6 Years 3 Months | Current |
| Venkata Durga Prasad Kadambala | Director | 09 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Dermazone Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aassk Pharmaceuticals Private Limited | ₹11.54 Cr (FY 2025) | 7.0% | Tiruvallur, Tamil Nadu, India | |||
| Marmas Enterprises Private Limited | ₹11.52 Cr (FY 2024) | -7.0% | Hyderabad, Telangana, India | |||
| Genmed Shoppes Private Limited | ₹11.51 Cr (FY 2024) | 142.0% | Surat, Gujarat, India | |||
| Dermazone Pharmaceuticals Private Limitedthis company | ₹11.44 Cr (FY 2024) | ₹33.04 Lakh | 2.9% | 22.0% | Thane, Maharashtra, India | |
| Saluja Medicose Private Limited | ₹11.44 Cr (FY 2025) | -1.0% | Delhi, India | |||
| Remedex Pharma Private Limited | ₹11.44 Cr (FY 2025) | 4.0% | Thiruvananthapuram, Kerala, India | |||
| Fenestra Pharmaceuticals Private Limited | ₹11.43 Cr (FY 2025) | 3.0% | Bangalore, Karnataka, India | |||
| Masaya Pharmaceuticals Private Limited | ₹11.4 Cr (FY 2024) | 40.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Dermazone Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Dermazone Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Dermazone Pharmaceuticals Private Limited, buy the company report.
Legal cases
Dermazone Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Commercial suit | Filed against the company by General Medicine Therapeutics Private Limited | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Glaxo Group Limited | Disposed |
To see the full case history of Dermazone Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dermazone Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dermazone Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCD8225G1ZM | Telangana | Active | 17 Jul 2020 |
To see the full GST registrations and return filing status of Dermazone Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dermazone Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Venkata Smita Sistla was appointed as Director on 03 Oct 2020.
AGM
Dermazone Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Dermazone Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Venkata Smita Sistla was appointed as Director.
Appointed
Vara Lakshmi Bikkasani was appointed as Director.
Appointed
Venkata Durga Prasad Kadambala was appointed as Director.
Incorporation
09 Jul 2020
Dermazone Pharmaceuticals Private Limited was registered on 09 Jul 2020 with Roc Mumbai & aged 6 years 3 months as per MCA records.
Frequently asked questions
Dermazone Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 July 2020 (6+ years old) and is registered under CIN U24230MH2020PTC341612.
Dermazone Pharmaceuticals has 3 current directors:
- Venkata Smita Sistla - Director
- Vara Lakshmi Bikkasani - Director
- Venkata Durga Prasad Kadambala - Director
The latest financial statements of Dermazone Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Dermazone Pharmaceuticals is 36AAHCD8225G1ZM, registered in Telangana.
The CIN (Corporate Identification Number) of Dermazone Pharmaceuticals is U24230MH2020PTC341612. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dermazone Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending. Most are in the district courts.
Dermazone Pharmaceuticals was incorporated on 09 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dermazone Pharmaceuticals by revenue are Aassk Pharmaceuticals Private Limited, Marmas Enterprises Private Limited, Genmed Shoppes Private Limited, Saluja Medicose Private Limited, Remedex Pharma Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Venkata Smita Sistla was appointed as Director on 03 Oct 2020. Vara Lakshmi Bikkasani was appointed as Director on 09 Jul 2020. Venkata Durga Prasad Kadambala was appointed as Director on 09 Jul 2020.
Yes, Dermazone Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-33-0002048).
Dermazone Pharmaceuticals can be reached through the website dermazone.in. Its registered office is in Thane, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages